Spots Global Cancer Trial Database for limited stage lung small cell carcinoma

Every month we try and update this database with for limited stage lung small cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer	NCT04155034	Extensive Stage... Limited Stage L... Lung Small Cell...	Magnetic Resona... Prophylactic Cr...	18 Years -	SWOG Cancer Research Network
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer	NCT03995667	Extensive Stage... Limited Stage L... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Questionnaire A... Tumor Treating ...	22 Years -	OHSU Knight Cancer Institute
Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer	NCT05191797	Extensive Stage... Limited Stage L...	Bomedemstat Atezolizumab	18 Years -	University of Washington
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs	NCT03896503	Bladder Small C... Extensive Stage... Extrapulmonary ... Limited Stage L... Platinum-Resist... Platinum-Sensit... Prostate Small ... Recurrent Lung ...	Berzosertib Biopsy Biospecimen Col... Computed Tomogr... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer	NCT03995667	Extensive Stage... Limited Stage L... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Questionnaire A... Tumor Treating ...	22 Years -	OHSU Knight Cancer Institute
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs	NCT03896503	Bladder Small C... Extensive Stage... Extrapulmonary ... Limited Stage L... Platinum-Resist... Platinum-Sensit... Prostate Small ... Recurrent Lung ...	Berzosertib Biopsy Biospecimen Col... Computed Tomogr... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer	NCT05353439	Extensive Stage... Limited Stage L... Platinum-Resist... Platinum-Sensit... Recurrent Lung ...	Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Tazemetostat Hy... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer	NCT06140407	Limited Stage L... Stage I Lung Ca... Stage II Lung C... Stage III Lung ...	Cisplatin Carboplatin Etoposide Pembrolizumab Computed Tomogr... Positron Emissi... Magnetic Resona... Biospecimen Col... Radiation Thera...	18 Years -	Vanderbilt-Ingram Cancer Center
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)	NCT03811002	Limited Stage L... Stage I Lung Ca... Stage II Lung C... Stage III Lung ...	3-Dimensional C... Atezolizumab Biospecimen Col... Carboplatin Cisplatin Etoposide Intensity-Modul... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer	NCT05353439	Extensive Stage... Limited Stage L... Platinum-Resist... Platinum-Sensit... Recurrent Lung ...	Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Tazemetostat Hy... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer	NCT05353439	Extensive Stage... Limited Stage L... Platinum-Resist... Platinum-Sensit... Recurrent Lung ...	Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Tazemetostat Hy... Topotecan Hydro...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: